Advertisement

Author: Physician's Weekly Admin

Oral Roxadustat in CKD Patients with Anemia

Roxadustat acts as a HIF prolyl-hydroxylase inhibitor and increases the endogenous production of erythropoietin and stimulates the production of hemoglobin in red blood cells. The objective of this study is to evaluate the...

Read More

For latest news and updates
Email-id is invalid